AIDS Survival Project

AIDS Survival Project has been a proud supporter of the Global Campaign for Microbicides since 1999. This open letter from campaign director, Lori Heise explains the excitement and the challenges presented at the year's International AIDS Conference....

In July 2006, the Centers for Disease Control (CDC) published a report outlining the results of a study done with 10,030 Men Who Have Sex with Men (MSM) by the National HIV Behavioral Surveillance (NHBS) System. Risk behavior data was collected bet...

The March 2006 issue of Harper's Magazine contains an article titled "Out of Control, AIDS and the Corruption of Medical Science." Unfortunately, this article represents the latest round of attacks from "AIDS denialists." These individuals hold to th...

As the old saying goes, two things are certain: death and taxes. We could just as easily add two more certainties to the list: prostitution and terrorism. Arguably, the threat of terrorism has always been around. And prostitution -- well, why do yo...

There has been a growing discussion recently about coverage of HIV/AIDS by the U.S. news media. Because journalists have reported increasing difficulty in getting their media organizations to run HIV/AIDS stories, questions naturally arise about wh...

At the end of July, the Centers for Disease Control (CDC) held its 2003 National HIV Prevention Conference in Atlanta. The 3, 400 attendees included people living with HIV/AIDS, community workers, researchers and public health staff. With several h...

Recreational/Street Drug/Abused PrescriptionHIV/Prescription MedicationInteractionCommentsAlcoholABC/Ziagen/AbacavirIncreases ABC levels in blood. One study observed a 41% increase in ABC.1ABC is metabolized by alcohol dehydrogenase, therefore increa...

This is not the first article we at ATI have ever written about bioelectrical impedance analysis (BIA), and we suspect that it will not be the last. BIA's continue to prove their importance in the clinical assessment and care of people living with HI...

On October 26, 2001, the Food and Drug Administration (FDA) approved a new drug for the treatment of HIV disease. Tenofovir (brand name Viread), the first in a new class of HIV medications called the nucleotide reverse transcriptase inhibitors, has t...

Taken from an article by Dan H. Karasic and James W. Dilley

Antiretroviral drugs -- especially protease inhibitors -- may interact with medications used to treat mood and anxiety disorders. Protease inhibitors have varying degrees of inhibition of t...